The pharmaceutical industry has spent decades optimizing for caution. Clinical research is heavily regulated, operationally complex, and built around systems designed to minimize risk rather than accelerate change. That is why Merck & Co.’s approach to artificial intelligence stands out. The company is not treating AI as a productivity add-on…